Phreesia (NYSE:PHR) (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.
Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems. Its platform supports specialty-specific intake workflows for outpatient clinics, health systems, physician practices and academic medical centers. In addition to core registration features, Phreesia provides clinical screening, automated reminders and compliance monitoring to help providers meet quality and regulatory requirements.
Phreesia’s subscription-based model includes fees for device infrastructure and per-session charges for patient engagements. The company serves a broad customer base—ranging from small practices to large integrated delivery networks—and has expanded partnerships with payers to deliver membership and risk-adjustment tools. This extended ecosystem approach enables Phreesia to capture patient-reported data that informs both care delivery and revenue cycle management.
Under the leadership of founder and CEO Chaim Indig, Phreesia has grown its platform deployment to thousands of clinical sites across the United States. The company continues to invest in product innovation—leveraging analytics and patient-generated insights—to drive digital transformation in healthcare, enhance operational efficiency and support better financial and clinical outcomes for providers.
